or
Remember me
Destroying Cancer at the Speed of Light® Clinical Study Underway (75 of 100 Patients Treated) Expected to complete enrollment at the end of 2024 Expected to complete study at the end of 2026
Back
Shares SHORT 863, Yes only 863. We have nearly 240 million shares outstanding, plus outstanding warrants and stock options. What's that tell you? No confidence in Theralase failing to triumph against all odds! See short history tab: https://ceo.ca/tlt Thanks; made2last
A daily snapshot of everything from market open to close.
The Road to Saving Lives: Clinical Study Underway
Address: 41 Hollinger Road Toronto, ON M4B 3G4 Canada Toll Free: 1-866-THE-LASE (843-5273) Local Phone: 416-699-LASE (5273) Email: info@theralase.com Fax: 416-699-5250